Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
tim Dixon sold 10.5 million shares on September 8th
https://ih.advfn.com/stock-market/USOTC/therapeutic-solutions-pk-TSOI/stock-news/89022882/statement-of-changes-in-beneficial-ownership-4
TSOI Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
\https://www.otcmarkets.com/stock/TSOI/profile
TSOI y PAUL btw Wonder if any of the investing public has any/all trade data relating to PAUL (institutional) era
Insiders no Form 4s filed or needed / Noteholders cashing out (as is their right) from Dixon's selling of (discounted?) paper to survive, well now sadly that's another story entirely
https://www.sec.gov/comments/s7-24-20/s72420-228879.htm
Any really wonder what’s happening to the pps. Get Real just look @ O/S y DTC. ONLY 1 person I know of??? Who can originate/sign off on those notes.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
On January 4, 2022, we issued 1,034,482 shares of common stock for $30,000 of accrued salaries.
On January 14, 2022, we issued 4,158,759 shares of common stock for the complete conversion of $56,975 for convertible note dated July 12, 2021.
On February 4, 2022, we issued 4,778,689 shares of common stock for the complete conversion of $58,300 for convertible note dated August 2, 2021.
On February 14, 2022, we issued 24,500,000 shares of common stock, valued at $0.01 per share, for an investment in the Company’s Private Placement.
On February 24, 2022, we issued 10,000,000 shares of common stock, valued at $0.01 per share, for an investment in the Company’s Private Placement.
On February 23, 2022, we issued 149,402,390 shares of common stock, valued at $0.0208 per share, for a license.
On March 31, 2022, we issued 10,000,000 shares of common stock, valued at $0.01 per share, for an investment in the Company’s Private Placement.
On April 4, 2022,we issued 6,786,585 shares of common stock for the complete conversion of $83,475 for convertible note dated October 1. 2021.
On April 5, 2022, we issued 9,000,000 shares of common stock, valued at $0.0251 per share, for consulting services.
On May 2, 2022, we issued 7,000,000 shares of common stock, valued at $0.026 per share, for consulting services.
On May 2, 2022, we issued 3,571,994 shares of common stock for the complete conversion of $56,438 for convertible note dated November 2, 2021.
On May 3, 2022, we issued 2,000,000 shares of common stock, valued at $0.0254 per share, for consulting services.
On May 4, 2022, we issued 2,000,000 shares of common stock, valued at $0.0259 per share, for consulting services.
On May 24, 2022, we issued 2,000,000 shares of common stock, valued at $0.02261 per share, for consulting services.
On June 16, 2022, we issued 2.919.708 shares of common stock for the partial conversion of $40,000 for convertible note dated December 15, 2021.
On June 17, we issued 1,951,993 shares of common stock for the complete conversion of $26,938 for convertible note dated December 15, 2021.
Item 1. Legal Proceedings
From time to time, claims are made against us in the ordinary course of business, which could result in litigation. Claims and associated litigation are subject to inherent uncertainties and unfavorable outcomes could occur, such as monetary damages, fines, penalties or injunctions prohibiting us from selling one or more products or engaging in other activities. The occurrence of an unfavorable outcome in any specific period could have a material adverse effect on our results of operations for that period or future periods.
However, as of the date of this report, management believes the outcome of currently identified potential claims and lawsuits will not have a material adverse effect on our financial condition or results of operations.
https://www.otcmarkets.com/filing/html?id=16030841&guid=o1w-kKH-nwOCJth
Does a Pink Sheet company even have to file a Form 4? I do not believe so. If it has been done in the past, it was voluntary. Pink sheets do not have the same filing requirements of the higher tier OTC exchanges.
wery wery
And WHAT PERCENTAGE of Tim’s shares has he sold? He sold 10,000,000 out of basically 280,000,000? Uh oh!!!
VVERRY OBVOUSS
But, but, but how do you know that? Who will be curing the COPD market?
I see no sales from Tim or Tom. The smoke here obwious
the smoke here is that Tim vants all of you to hold onto your shares here until the P3 trials are concluded and FDA approval begins and ve can all fly to his palty backyard for some ribs and lemonade as appreaciation.
All sounds Dandy indeed, but unfortunaly tim dixon wants to see his shares at .011 price ... so if he is selling and not holding like we are supposed to? then why should you average down at .01 vhen in fact Tim is selling .01's ??????
If tim and ichim held during P3 trials .. that sends a whole new messege ... not this ... the messege Tim is sending to everyone is that P3 is not going as planned.
Tim….. we’re gonna cure COPD
Market…… no your not
another 1.2m scattered around on the bid side
so
w/ this haven been brought up
We bought for ARDS treatment, EUA, clinical trial. What we got instead is a shed in the middle of nowhere next to a national forest.
nothing has changed except pps why did you buy??
Tim sold 10 Million shares Thursday & Friday O well
I bought shares today Woo hoo
Once in their heads
And how long has Tim been printing himself shares? From the beginning when he started TSOI over a decade ago? It sure looks like it! Oh well, that never stopped people from investing! If potential shareholders through their preliminary due diligence didn’t like the way Tim obtained his shares, they didn’t have to become shareholders! Like it or not! So there’s that…
I see, the ship seemeth to sink, and who will get off 1st.
Why are Ichrim and Tim Dixon constant selling??
Dilution is what is awful. If Tim and his gang belive in this so much, I expect him to buy on the open market and file a form 4 like everyone else who believes in what they spew.
Why cant Tim file a form4 for his insider buys? Oh wait does he aktually pay for his shares or prints them off the zerox printer?
Yeah, awful that TSOI is committed to COPD and trying to cure it
RSI is way oversold as it is, I don't much more downside from here
.01 was going to be tested the way it was going, so not really surprised. I loaded up
Hopefully the rise back up happens now, or maybe MM's will run it hard soon
$TSOI
Let us know when you can post those filings!
Sry Tim, but vhen subs be printed, heads will roll
Sub .01
U must be kwazy
Whiever been selling from mid 2s to .01 must of called tim and said i neeed a pr to sell to put this fluffy cotton candy out.
Our commitment to COPD is based on the fact that treatments have largely been addressing symptoms,” said Timothy Dixon, President and CEO of the Company. “As part of our zeal to develop regenerative approaches to this problem, we are developing a pipeline of products that can fit into current COPD treatment protocols. The endogenous stem cell stimulating approach is being created as a maintenance therapy that will be used with the JadiCell approach.”
Has the trial started? Have all patients been enrolled?
Tim let everybody down. Him going quiet over past several months with.over 50 patents and nothing to talk about is telling.
Hate to say it. I guess you were right all along
sorry you finally came to this realization BB as have many it would seem
Tim Dickson files when he gets free shares but doesnt file when he sells. Or his cronies
Main reason he stays non reporting stink oh i mean pink
TIM Dickson and his gang must of sold like bandits. Doctors turned scientists turned.theives.
Digusting
Yes, once it stops and positive FDA trials info is released, this can recover, until then the slow bleed continues. We may see .005 before this gets the volume it will need to move back into pennyland. I will have fresh powder waiting for that time.
Cheerz
Don
it has not impact whatsoever...just pissing in the wind
I dont understand how gifting his personal shares to anyone affects us. I hope to do the same for my grandchildren someday. Best to gift when price is low so they can enjoy benifits of price increase.
Really only Tim can tell you that, everyone else would be just speculating.
Just think of the opportunity some investors had when they came to the conclusion that CEO Tim was a plumber and nothing more many months ago and the share price was much higher!
now GTSM back @ 01 @ 10:37:11 selling another 2.1m. Lowered my bids into subs to take another chance of hope one day as I believe in the science & perhaps one day Dixon may either learn to be a real businessman or simply just pass from this world & a real CEO be put in charge
One big question I have is can anyone tell me why our CEO gifted those 55 to 60,000,000 shares recently with the shape that we are in with no money to do anything and him crying that he didn’t have the money to pay for the IND’s. So what was the advantage or why a person would even do that at this point in time of the bad shape this company is in.
In my opinion I believe Tim’s ego has got the best of him and he can show us all he can do what he wants with this company. I don’t see how this can help him and he with the millions of shares that he has an item and then to gift more lol just doesn’t make sense. He doesn’t want to give up any power for a partnership but half of something is better than nothing. Tim’s poor little grandson isn’t even going to have a chance to run this company. It will be belly up.
A reverse split is out of the question because if he did that it would be so big and then the shorts would come in and have one hell of a heyday taking everything back down to where we’re at now.
But I will listen to anyone who can give me a sensible statement of why granting these millions of granting or gifting how we wanna call it millions of shares at this point in time
I really don’t believe anyone can give me a sensible answer on that but we’ll see I’m listening
nice to see a little buying come in to absorb those unlimited shares that never seem to stop entering the market 300k sadly not sub 01s go to my 3 GKs tough part I had forgotten about that GTC order strange how it filled though.
He continues to lead his own sheep to slaughter. Probably hands down one of the most ridiculous CEOs I’ve seen in pinks. He just doesn’t get it,
Hey let’s hide phase 3 trials said nobody ever.
Like catching a falling knife right now. This ought to bring out some more crying. Now even a little good news can't stop the downward trend.
TSOI subs printed 009625 @ 9:38:57
2,004,850 on ask @ 0.01 w/ 2.3m @ 0112 500k bidding 0091
so today is the day for subs to come...way to go Dixon way to lead this damn self proclaimed MOAB into the abyss
Therapeutic Solutions International Develops Post JadiCell Maintenance Therapy for Chronic Obstructive Pulmonary Disease (COPD)
Phase III COVID-19 ARDS Company Continues Quest to Cure COPD Through Developing Clinically Applicable Solutions
https://www.businesswire.com/news/home/20220912005532/en/
Followers
|
528
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
64379
|
Created
|
10/04/08
|
Type
|
Free
|
Moderators BigBadWolf johnnytrader33 JMC$ Yooperman Hogwarts |
Preclinical Data Suggests QuadraMune™ Prevents Stress-Induced Suppression of Neurogenesis More Effectively than Prozac
OCEANSIDE, Calif., Dec. 9, 2020 /PRNewswire/ -- Therapeutics Solution International, Inc., (OTC Markets: TSOI), announced today new data suggesting the possibility that QuadraMune™ may mediate neuroprotective activity through preserving the ability of regenerative brain cells to proliferate subsequent to psychological stress.
The experiments, which involved exposing mice to established stressors, demonstrated that specific areas of the brain associated with production of new brain cells are damaged by stress. In agreement with previously published research, administration of fluoxetine (Prozac™) protected the brain from stress-induced damage. Surprisingly, QuadraMune™ administration appeared superior to Prozac™ at stimulating proliferation of new brain cells.
"QuadraMune™ which is currently in a clinical trial for prevention of COVD-191, has also been demonstrated to possess anti-inflammatory activity in other clinical trials, suppressing cytokines such as IL-62, which are known to be involved in depression3 and suicide4" said Kalina O'Connor, Director of Campbell Neurosciences and co-inventor on the patent. "Given major depressive disorder causes a significant risk for suicide, we are highly interested in exploring the use of QuadraMune™ for preventing suicide."
"Although much enthusiasm has been generated over the planned distribution of the COVID vaccine, at present little is being done to address mental health issues that are being exacerbated by the current pandemic" said Dr. James Veltmeyer, co-inventor of the patent, and Chief Medical Officer of the Company. "If current results are reproducible, the possibility that a nutraceutical would concurrently boost immunity while preserving mental health is highly enticing."
"It has not escaped us that COVID-19 is associated with increased inflammatory cytokines in the blood of patients, cytokines that also predispose to depression" said Famela Ramos, Vice President of Business Development for the Company. "It may be that the recent increase in suicides and suicide attempts is related biologically to activities of the coronavirus. It will be interesting to examine whether QuadraMune™ may modify putative negative mental effects of the virus."
"An estimated 17.3 million adults in the United States had at least one major depressive episode. This number represented 7.1% of all U.S. adults" stated Timothy Dixon, President and CEO of the Company. "We believe the Mission of our Company is not just providing a return on investment to our shareholders, but also increasing the quality of life for Americans. We are extremely pleased to report this unexpected finding with significant potential implications to advancing non-toxic means of helping patients with this terrible condition."
1 QuadraMune(TM) for Prevention of COVID-19 - Full Text View - ClinicalTrials.gov
2 Therapeutic Solutions International Announces Positive Preclinical and Clinical Evaluation of Nutritional Supplement QuadraMune™, Designed to Protect Against COVID-19 | BioSpace
3 Ting et al. Role of Interleukin-6 in Depressive Disorder. Int J Mol Sci. 2020 Mar 22;21(6):2194.
4 O'Donovan et al. Suicidal ideation is associated with elevated inflammation in patients with major depressive disorder. Depress Anxiety. 2013 Apr;30(4):307-14.
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |